These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3221792

  • 21. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM, Ramirez JC, Rodríguez D, Rodríguez JR, Sano G, Zavala F, Esteban M.
    J Immunol; 1999 Jun 01; 162(11):6724-33. PubMed ID: 10352291
    [Abstract] [Full Text] [Related]

  • 22. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
    Lusso P, Markham PD, Ranki A, Earl P, Moss B, Dorner F, Gallo RC, Krohn KJ.
    J Immunol; 1988 Oct 01; 141(7):2467-73. PubMed ID: 3262661
    [Abstract] [Full Text] [Related]

  • 23. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
    Pal R, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Markham P, Lu S.
    Virology; 2006 May 10; 348(2):341-53. PubMed ID: 16460776
    [Abstract] [Full Text] [Related]

  • 24. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X, Liu L, Ren L, Qiu C, Wan Y, Xu J.
    Vaccine; 2007 Dec 17; 25(52):8874-84. PubMed ID: 18061316
    [Abstract] [Full Text] [Related]

  • 25. Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.
    Evans TG, Frey S, Israel H, Chiu J, El-Habib R, Gilbert P, Gaitan A, Montefiori DC, HIV Vaccine Trials Network (HVTN 803).
    Vaccine; 2004 Jun 30; 22(20):2626-30. PubMed ID: 15193388
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Experimental vaccination against HIV-1 protects the chimpanzee against challenge with injections of infected lymphocytes].
    Girard M, Kieny MP, Barré-Sinoussi F, Nara P, Muchmore E, Fultz P.
    Bull Acad Natl Med; 1992 Jun 30; 176(6):921-34; discussion 935. PubMed ID: 1464038
    [Abstract] [Full Text] [Related]

  • 30. Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use.
    Valdés I, Hermida L, Gil L, Lazo L, Castro J, Martín J, Bernardo L, López C, Niebla O, Menéndez T, Romero Y, Sánchez J, Guzmán MG, Guillén G.
    Int J Infect Dis; 2010 May 30; 14(5):e377-83. PubMed ID: 19773190
    [Abstract] [Full Text] [Related]

  • 31. Cell-mediated immune response to mumps virus infection in man.
    Chiba Y, Dzierba JL, Morag A, Ogra PL.
    J Immunol; 1976 Jan 30; 116(1):12-5. PubMed ID: 1245735
    [Abstract] [Full Text] [Related]

  • 32. Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.
    Myagkikh M, Alipanah S, Markham PD, Tartaglia J, Paoletti E, Gallo RC, Franchini G, Robert-Guroff M.
    AIDS Res Hum Retroviruses; 1996 Jul 20; 12(11):985-92. PubMed ID: 8827214
    [Abstract] [Full Text] [Related]

  • 33. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK, Reed DL, Matthews TJ, Langlois AJ, Ahearne PA, Petteway SR, Weinhold KJ.
    AIDS Res Hum Retroviruses; 1987 Jul 20; 3(4):409-22. PubMed ID: 2833917
    [Abstract] [Full Text] [Related]

  • 34. [AIDS vaccines: an enigma in vaccine development].
    Dorner F, Barrett N.
    Wien Klin Wochenschr; 1990 Jan 19; 102(2):51-8. PubMed ID: 1689919
    [Abstract] [Full Text] [Related]

  • 35. Expression of AIDS virus envelope gene in recombinant vaccinia viruses.
    Hu SL, Kosowski SG, Dalrymple JM.
    Nature; 1990 Jan 19; 320(6062):537-40. PubMed ID: 3008002
    [Abstract] [Full Text] [Related]

  • 36. [Virus-induced autoimmunity phenomena in experimental animals (author's transl)].
    Sprössig M, Wutzler P, Färber I, Schweizer H, Schneider J.
    Exp Pathol (Jena); 1977 Jan 19; 13(1):52-7. PubMed ID: 191276
    [Abstract] [Full Text] [Related]

  • 37. Pathogenesis and natural history of HIV infection.
    Sleasman JW, Goodenow MM.
    J Fla Med Assoc; 1991 Oct 19; 78(10):678-81. PubMed ID: 1753233
    [Abstract] [Full Text] [Related]

  • 38. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
    Franchini G, Tartaglia J, Markham P, Benson J, Fullen J, Wills M, Arp J, Dekaban G, Paoletti E, Gallo RC.
    AIDS Res Hum Retroviruses; 1995 Feb 19; 11(2):307-13. PubMed ID: 7742044
    [Abstract] [Full Text] [Related]

  • 39. [Sensitization against the antigens of the brain after experimental vaccinia infection. I. Evidence for cell-mediated immune response to brain-antigens (author's transl)].
    Huber HC, Zinn KH, Hochstein-Mintzel V, Simon J, Stickl H.
    Zentralbl Bakteriol Orig A; 1975 Jun 19; 232(1):1-7. PubMed ID: 51549
    [Abstract] [Full Text] [Related]

  • 40. AIDS vaccines: concepts and first trials.
    Sonigo P, Montagnier L, Tiollais P, Girard M.
    Immunodefic Rev; 1989 Jun 19; 1(4):349-66. PubMed ID: 2698645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.